Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse.

Authors :: Beziat G
Tavitian S
Arnaud FX
Izar F
Attal J
Borel C
Recher C
Ducassou A
Source :: Journal of contemporary brachytherapy [J Contemp Brachytherapy] 2022 Dec; Vol. 14 (6), pp. 601-604. Date of Electronic Publication: 2022 Dec 30.
Publication Year :: 2022
Abstract: Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this disease. Two cases of uterine cervix-limited AML relapse showed that brachytherapy may be an effective therapeutic option in this setting along with chemotherapy, with good tolerance.<br />Competing Interests: The authors report no conflict of interest.<br /> (Copyright © 2022 Termedia.)